| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.9M | — | +10.7% |
| Cost of Revenue | $1.3M | — | +34.4% |
| Gross Profit | $2.7M | — | +2.2% |
| R&D Expense | $164K | — | +33.2% |
| SG&A Expense | $1.5M | — | -9.7% |
| Operating Income | $1.2M | — | +23.1% |
| Pre-tax Income | $1.3M | — | +18.0% |
| Income Tax | $286K | — | +0.9% |
| Net Income | $971K | — | +24.2% |
| EPS (Basic) | $0.21 | — | +23.5% |
| EPS (Diluted) | $0.21 | — | +23.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.1M | -1.4% | +48.5% |
| Short-term Investments | $0 | — | -100.0% |
| Accounts Receivable | $3.2M | +14.2% | +19.6% |
| Inventory | $1.3M | -18.6% | -18.4% |
| Current Assets | $13.5M | +1.6% | +9.2% |
| Total Assets | $14.9M | +3.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $444K | — | -39.6% |
| Investing Cash Flow | $0 | — | -100.0% |
| Financing Cash Flow | -$557K | — | -500.3% |
| +6.3% |
| Current Liabilities | $423K | -14.3% | -48.1% |
| Total Liabilities | $1.6M | +6.5% | -11.4% |
| Stockholders' Equity | $13.3M | +3.4% | +9.0% |